Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

• Between 40 to 80 years of age

• Physician diagnosed chronic obstructive pulmonary disease (COPD) ≥1 year

• Post-bronchodilator forced expiratory volume in 1 second (post-BD FEV1) ≥ 20% and ≤ 70% of predicted value and FEV1/FVC (forced expiratory volume in 1 second /forced vital capacity) \<0.70

• Former or current smokers ≥10 pack-years

• Chronic Airways Assessment Test (CAAT) ≥10

• ≥2 moderate or ≥1 severe COPD exacerbations in the prior year

• Triple (ICS+LABA+LAMA) COPD therapy ≥12 consecutive weeks

• EOS (blood eosinophil count) ≥ 150 cells/μL

• 18.0 ≤ Body Mass Index ≤ 40.0 kg/m2